Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 217-228 of 4,306
Behavioral study icon
RecruitingNCT05617898

Determining the Role of Social Reward Learning in Social Anhedonia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Alabama at Birmingham
Condition
Schizophrenia
Drug study icon
RecruitingNCT06224530

Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk

This summary needs review. Please check the official study record and contact the research team for details.

In London
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 40 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
Drug study icon
RecruitingNCT06482554

Lumateperone for the Improvement of Apathy in people with Psychotic Symptoms.

This summary needs review. Please check the official study record and contact the research team for details.

In Shreveport
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Louisiana State University Health Sciences Center Shreveport
Condition
Schizophrenia
Drug study icon
RecruitingNCT05980949

Safety study of KarXT in Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Canada, ...

Multiple locations, including Anaheim
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 55 Years to 90 Years
Countries
United States, France, Canada, ...
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT06194344

The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicide prevention Among Inpatients With Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, SuicidalityBehavioralOver 18 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia, Suicidality
Other study type icon
Not Yet RecruitingNCT07330843

Assessment and Evolution of Narrative Identity and Its Relationship to Subjective Multidimensional Well-being and Multidimensional Recovery in First Episode Psychosis

This study is not yet recruiting in France. It focuses on Schizophrenia.

In Nîmes
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 16 Years to 30 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Nīmes
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.